94 studies found for: Open Studies | "Urinary Bladder, Overactive"
Study of Overactive Bladder in Women With Prolapse
Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder
A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice
This is a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in Women
Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment
Gene Expression in the Overactive Bladder in Children
Therapy of the Overactive Bladder Syndrome
Bladder Thermal Distention for Patients With Refractory Overactive Bladder
Painless Laser Therapy for Overactive Bladder
|13||Not yet recruiting||
Efficacy of Transcutaneous Nerve Stimulation on Improvement of Overactive Bladder Symptoms
Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder
Association Between Metabolic Syndrome and Serum Nerve Growth Factor Levels in Women With Overactive Bladder
Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder
Does Bladder Training Improve the Efficacy of Nerve Stimulation in Women With Refractory Overactive Bladders
|18||Not yet recruiting||
Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.
Post-marketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron.
Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome
† Indicates status has not been verified in more than two years